Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes

Acta Diabetologica

Volumn 50, Issue 3, 2013, Pages 437-442

  Sartore, Giovanni ^a   Chilelli, Nino Cristiano ^a   Burlina, Silvia ^a   Lapolla, Annunziata ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Continuous glucose monitoring (CGM); Diabetic retinopathy; Glucose variability; Type 1 diabetes; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; TROPICAMIDE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; OPHTHALMOSCOPY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84879234525     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0459-9     Document Type: Article

References (35)

1. Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179-183
2. Klein R (2008) Epidemiology of Diabetic Retinopathy. In Duh E (ed.) Diabetic Retinopathy
3. Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124-136
4. DCCT research group (1993) The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329:977-986
5. UK Prospective Diabetes Study group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853
6. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN (2008) Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited. Diabetes 57:995-1001
7. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058-1070
8. Chang CM, Hsieh CJ, Huang JC, Huang IC (2012) Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. doi: 10.1007/s00592-012-0398-x
9. Nalysnyk L, Hernandez-Medina M, Krishnarajah G (2010) Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 12:288-298
10. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH (2010) Glucose variability: does it matter? Endocr Rev 31:171-182
11. De Block C, Manuel-y-Keenoy B, Van Gaal L (2008) A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol 2:718-727
12. Hoekstra JB, Nathan DMJ, Borg R, Zheng H, Schoenfeld D, Heine RJ for the A1c-Derived Average Glucose (ADAG) Study Group (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31:1473-1478
13. Sartore G, Chilelli NC, Burlina S, Stefano PD, Piarulli F, Fedele D, Mosca A, Lapolla A (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol. doi: 10.1007/s00592-012-0391-4
14. Klonoff DC (2005) Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 28:1231-1239
15. Ceriello A, Ihnat MA (2010) 'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. Diabet Med 27:862-867
16. Rodbard D (2009) New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 11:551-565
17. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644-656
18. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 7:253-263
19. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W (2006) Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29:2433-2438
20. Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Arlie house classification. ETDRS report number 10. Ophtalmology 98:786-806
21. Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677-1682
22. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW on behalf of the DPV-Wiss Study Group (2011) Diabetic retinopathy in type 1 diabetes - a contemporary analysis of 8,784 patients. Diabetologia 54:1977-1984
23. Kempen JH, O' Colmain BJ, Leske MC et al (2004) The prevalence of diabetic retinopathy among adults in the United States. Arch Ophtalmol 122:552-563
24. Bolli GB, Andreoli AM, Lucidi P (2011) Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era. Diabetes Technol Ther 13:S43-S52
25. Stolar M (2010) Glycemic control and complications in type 2 diabetes mellitus. The American Journal of Medicine 123:S3-S11
26. Kohnert KD, Augstein P, Zander E, Heinke P, Peterson K, Freise EJ et al (2009) Glycemic variability correlates strongly with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 32:1058-1062
27. Lam CSY, Benzie IFF, Choi SW, Chan LYL, Yeung VTF, Woo GC (2011) Relationships among diabetic retinopathy, antioxidants, and glycemic control. Optom Vis Sci 88:251-256
28. Monnier L, Colette C, Owens D (2012) The glycemic triumvirate and diabetic complications: is the whole greater than the sum of its component parts? Diabetes Res Clin Pract 95:303-311
29. Kilpatrick ES, Rigby AS, Atkin SL (2009) Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 32:1901-1903
30. Zoppini G, Verlato G, Targer G et al (2008) Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? NMCD 19:334-339
31. Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y (2011) The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients. Diabetes Res Clin Pract 91:e40-e42
32. Patton SR, Midyett LK, Dolan LM, Powers SW (2011) A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous monitoring and self-monitoring data. Diabetes Technol Ther 14:239-243
33. Vazeou A (2011) Continuous blood glucose monitoring in diabetes treatment. Diabetes Res Clin Pract 93:S125-S130
34. Monnier L, Colette C, Owens DR (2008) Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2:1094-1100
35. Ceriello A, Ihnat MA, Thorpe JE (2009) Clinical review 2: the "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 94:410-415